Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05931887 · ClinicalTrials.gov registry record · NA
Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention
A NA study of Catheter Infection and Catheter Related Complication, sponsored by Silq Technologies Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05931887 is a NA study of Catheter Infection and Catheter Related Complication that is actively recruiting participants, run by Silq Technologies Corporation. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05931887, a NA study of Catheter Infection and Catheter Related Complication, is actively recruiting participants, sponsored by Silq Technologies Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce catheter associated complications in subjects that require a long-term indwelling Foley catheter when compared to other commercially available Foley catheters.
Conditions Studied
Interventions
- DEVICE SILQ ClearTract 100% Silicone 2-Way Foley Catheter
Study Locations (1)
California
- Rancho Los Amigos National Rehabilitation Center - Downey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2025-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05931887
The ClinicalTrials.gov registry entry for NCT05931887 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Silq Technologies Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Catheter Infection appearing as the primary indexed condition, and to 1 intervention - of which SILQ ClearTract 100% Silicone 2-Way Foley Catheter is the first listed.
NCT05931887 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05931887 about?
NCT05931887 is a clinical study titled "Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention". To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce catheter associated complications in subjects that require a long-term indwelling Foley catheter when compared to other commercially available Foley catheters.
What is the current status of trial NCT05931887?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-07-26. Estimated completion is 2025-07-26.
What conditions does trial NCT05931887 study?
This clinical trial studies the following conditions: Catheter Infection, Catheter Related Complication, Catheter Blockage, Catheter Calcification.
What interventions are being tested in trial NCT05931887?
The interventions under investigation include: SILQ ClearTract 100% Silicone 2-Way Foley Catheter (DEVICE).
Who is sponsoring clinical trial NCT05931887?
This trial is sponsored by Silq Technologies Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05931887 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheter Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.